FDA makes moves to advance ALS research ahead of upcoming Am

The US FDA’s action plan for rare neurodegenerative diseases including ALS, foreshadows steps to improve ALS research and treatment availability.

Related Keywords

Canada , Massachusetts , United States , Neil Thakur , Sanofi Rilutek , Andrew Powaleny , Tanabe Pharma Radicava , Public Affairs , Department Of Health , Human Services , Drug Administration , Health Canada , Advisory Committee Adcom For Amylyx Pharmaceutical , Contamination Control Floor Solutions , Amylyx Pharmaceutical , Merit Cudkowicz , President Biden , Accelerating Access , Critical Therapies , Mitsubishi Tanabe Pharma Radicava , Drug Evaluation , Accelerating Rare Disease Cures , Amyotrophic Lateral Sclerosis Clinic , Massachusetts General , Massachusetts General Hospital , Pharmaceutical Technology , Prescription Drug User Fee Act , Test Solutions , Pharmaceutical Drug Delivery , Analysis Techniques ,